FIELD: pharmaceutical industry. SUBSTANCE: present invention describes isozerine derivatives of formula I: wherein Y is -CH=CH-; R1 is hydrogen or halogen; R2 is halogen, CH3,OCH3,NO2 or CF3, and n is 0-3, A is carboxy, or pharmaceutically acceptable nontoxic salts thereof, in vivo hydrolysable esters. Said derivatives are prepared by reacting compound II with compound III . Compounds of formula I show lenkotriene antagonistic activity. EFFECT: improved properties of the pharmaceutical composition. 9 cl, 24 ex, 2 tbl
Authors
Dates
1999-02-20—Published
1993-08-05—Filed